META, ELDA
 Distribuzione geografica
Continente #
EU - Europa 654
Totale 654
Nazione #
IT - Italia 654
Totale 654
Città #
Genova 437
Rapallo 123
Genoa 93
Bordighera 1
Totale 654
Nome #
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein Kinase (DMPK)1 as a novel angiogenesis target 113
Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential anti-tuberculosis agents. 109
Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis 96
3-Cyclopentyloxy-4-Methoxyphenyl-isoxazoline derivatives as new PDE4 inhibitors. 82
Development of imidazo-pyrazole derivatives as potential antimetastatic agents in neuroblastoma 66
The kinase inhibitor pyrazolyl-urea GeGe3 inhibits angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target 47
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 47
The Kinase Inhibitor Pyrazolyl-Urea Gege3 Inhibits Angiogenesis And Reveals Dystrophia Myotonica Protein Kinase (DMPK)1 As A Novel Angiogenesis Target 38
New kinases targeted compounds as possible antiangiogenic and antimetastatic agents 36
New series of pyrazoles and imidazo‐pyrazoles targeting different cancer and inflammation pathways 35
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 14
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 12
Totale 695
Categoria #
all - tutte 2.537
article - articoli 1.985
book - libri 0
conference - conferenze 552
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 0 15 12
2019/2020195 21 5 6 7 10 21 30 13 18 33 26 5
2020/202158 1 4 4 8 0 9 3 10 6 8 4 1
2021/2022115 10 5 2 8 4 8 2 33 13 15 0 15
2022/2023149 11 17 2 22 20 18 0 13 14 0 27 5
2023/202476 4 14 2 15 19 9 5 2 2 4 0 0
Totale 695